Determination of the residual efficacy of broflanilide (VECTRON™ T500) insecticide for indoor residual spraying in a semi-field setting in Ethiopia
View abstract on PubMed
Summary
This summary is machine-generated.VECTRON™ T500 demonstrated over 80% mosquito mortality for nine months on various surfaces, outperforming Actellic 300CS in Ethiopia. This insecticide shows promise for malaria vector control and addressing insecticide resistance.
Area Of Science
- Entomology
- Medical Entomology
- Public Health
Background
- Indoor residual spraying (IRS) relies on insecticide rotation for malaria vector control and managing insecticide resistance.
- Insecticide decay rates are critical for national malaria control programs.
- VECTRON™ T500, containing broflanilide, is a new insecticide formulation with potential for IRS.
Purpose Of The Study
- To evaluate the residual efficacy of VECTRON™ T500 against malaria vectors.
- To assess VECTRON™ T500's performance on diverse wall surfaces (mud, dung, paint, cement).
- To determine the decay rate of VECTRON™ T500 over time in Ethiopia.
Main Methods
- Bioassays were conducted using laboratory-reared Anopheles arabiensis mosquitoes.
- Seven test huts with different wall types were used: mud, dung, painted, and cemented.
- Huts were treated with VECTRON™ T500, Actellic 300CS, or water (control).
Main Results
- VECTRON™ T500 achieved over 80% mosquito mortality across all wall types for nine months.
- Actellic 300CS maintained over 80% mortality for six months, with a sharp decline on dung surfaces thereafter.
- VECTRON™ T500 exhibited superior residual efficacy compared to Actellic 300CS.
Conclusions
- VECTRON™ T500 provides effective mosquito mortality for up to nine months on various surfaces.
- The formulation's extended efficacy suggests it is a strong candidate for IRS programs in malaria-endemic regions.
- VECTRON™ T500 could be a valuable tool in Ethiopia's malaria vector control efforts.

